{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33823"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33823","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Activin A Promotes Activin B Upregulation Through SOX9 in Chronic Kidney Disease","abstract":"Chronic kidney disease (CKD) affects an estimated 10% of the global population, with tubulointerstitial fibrosis representing the common pathological endpoint across nearly all disease etiologies. Proximal tubular epithelial cells (PTECs) are increasingly recognized as active drivers of this process through the secretion of profibrotic cytokines, including Activin A and Activin B, members of the TGF-β superfamily. While Activin A is an established profibrotic mediator, emerging evidence implicates Activin B as a potentially sustained contributor to fibrosis, and preliminary data from our lab suggested that PTEC-specific deletion of Inhba (Activin A) reduces Activin B expression in a murine model of renal fibrosis. This thesis tested the hypothesis that Activin A regulates Activin B expression through the transcription factor SOX9, and investigated whether this axis mediates paracrine crosstalk between PTECs and fibroblasts. Using HK-2 cells and a PTEC-specific Inhba knockout mouse model of unilateral ureteral obstruction (UUO), Activin A activation (via recombinant drug), and Activin A inhibition (via siRNA knockdown and neutralizing antibody), consistently and bidirectionally altered Activin B mRNA and protein expression, establishing that Activin A acts upstream of Activin B. Activin A was also shown to be both necessary, in vivo, and sufficient, in vitro, for nuclear SOX9 accumulation, a marker of its transcriptionally active state. Dual immunofluorescence further revealed that SOX9-positive PTECs were spatially associated with regions of enriched myofibroblast activation, and conditioned medium from Activin A-treated PTECs induced SOX9 expression in fibroblasts in an Activin B-dependent manner, though this latter effect did not reach statistical significance. Together, these findings support a model in which Activin A drives SOX9-dependent Activin B upregulation in PTECs, positioning this axis as a candidate mechanism of epithelial-fibroblast crosstalk and a potential therapeutic target in CKD.","abstract_html":"Chronic kidney disease (CKD) affects an estimated 10% of the global population, with tubulointerstitial fibrosis representing the common pathological endpoint across nearly all disease etiologies. Proximal tubular epithelial cells (PTECs) are increasingly recognized as active drivers of this process through the secretion of profibrotic cytokines, including Activin A and Activin B, members of the TGF-β superfamily. While Activin A is an established profibrotic mediator, emerging evidence implicates Activin B as a potentially sustained contributor to fibrosis, and preliminary data from our lab suggested that PTEC-specific deletion of Inhba (Activin A) reduces Activin B expression in a murine model of renal fibrosis. This thesis tested the hypothesis that Activin A regulates Activin B expression through the transcription factor SOX9, and investigated whether this axis mediates paracrine crosstalk between PTECs and fibroblasts. Using HK-2 cells and a PTEC-specific Inhba knockout mouse model of unilateral ureteral obstruction (UUO), Activin A activation (via recombinant drug), and Activin A inhibition (via siRNA knockdown and neutralizing antibody), consistently and bidirectionally altered Activin B mRNA and protein expression, establishing that Activin A acts upstream of Activin B. Activin A was also shown to be both necessary, in vivo, and sufficient, in vitro, for nuclear SOX9 accumulation, a marker of its transcriptionally active state. Dual immunofluorescence further revealed that SOX9-positive PTECs were spatially associated with regions of enriched myofibroblast activation, and conditioned medium from Activin A-treated PTECs induced SOX9 expression in fibroblasts in an Activin B-dependent manner, though this latter effect did not reach statistical significance. Together, these findings support a model in which Activin A drives SOX9-dependent Activin B upregulation in PTECs, positioning this axis as a candidate mechanism of epithelial-fibroblast crosstalk and a potential therapeutic target in CKD.","abstract_has_math":false,"creators":["Bonifacio Proietto, S. Davide"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Medical Sciences (Blood and Cardiovascular)","school":null,"contributors":[],"advisors":["Krepinsky, Joan"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:32:20Z","subjects":[],"languages":["en"],"rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25593"],"render_values":[{"text":"https://doi.org/10.71548/25593","href":"https://doi.org/10.71548/25593","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33823","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33823","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33823","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Krepinsky, Joan"]},{"key":"dc:contributor.department","label":"Department","values":["Medical Sciences (Blood and Cardiovascular)"]},{"key":"dc:creator","label":"Author","values":["Bonifacio Proietto, S. Davide"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-14T18:30:09Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivs 2.5 Canada"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33823","https://doi.org/10.71548/25593"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Chronic kidney disease (CKD) affects an estimated 10% of the global population, with tubulointerstitial fibrosis representing the common pathological endpoint across nearly all disease etiologies. Proximal tubular epithelial cells (PTECs) are increasingly recognized as active drivers of this process through the secretion of profibrotic cytokines, including Activin A and Activin B, members of the TGF-β superfamily. While Activin A is an established profibrotic mediator, emerging evidence implicates Activin B as a potentially sustained contributor to fibrosis, and preliminary data from our lab suggested that PTEC-specific deletion of Inhba (Activin A) reduces Activin B expression in a murine model of renal fibrosis. This thesis tested the hypothesis that Activin A regulates Activin B expression through the transcription factor SOX9, and investigated whether this axis mediates paracrine crosstalk between PTECs and fibroblasts. Using HK-2 cells and a PTEC-specific Inhba knockout mouse model of unilateral ureteral obstruction (UUO), Activin A activation (via recombinant drug), and Activin A inhibition (via siRNA knockdown and neutralizing antibody), consistently and bidirectionally altered Activin B mRNA and protein expression, establishing that Activin A acts upstream of Activin B. Activin A was also shown to be both necessary, in vivo, and sufficient, in vitro, for nuclear SOX9 accumulation, a marker of its transcriptionally active state. Dual immunofluorescence further revealed that SOX9-positive PTECs were spatially associated with regions of enriched myofibroblast activation, and conditioned medium from Activin A-treated PTECs induced SOX9 expression in fibroblasts in an Activin B-dependent manner, though this latter effect did not reach statistical significance. Together, these findings support a model in which Activin A drives SOX9-dependent Activin B upregulation in PTECs, positioning this axis as a candidate mechanism of epithelial-fibroblast crosstalk and a potential therapeutic target in CKD."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Activin A Promotes Activin B Upregulation Through SOX9 in Chronic Kidney Disease"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Krepinsky, Joan"],"dc:contributor.department":["Medical Sciences (Blood and Cardiovascular)"],"dc:creator":["Bonifacio Proietto, S. Davide"],"dc:date.accessioned":["2026-10-14T18:30:09Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Chronic kidney disease (CKD) affects an estimated 10% of the global population, with tubulointerstitial fibrosis representing the common pathological endpoint across nearly all disease etiologies. Proximal tubular epithelial cells (PTECs) are increasingly recognized as active drivers of this process through the secretion of profibrotic cytokines, including Activin A and Activin B, members of the TGF-β superfamily. While Activin A is an established profibrotic mediator, emerging evidence implicates Activin B as a potentially sustained contributor to fibrosis, and preliminary data from our lab suggested that PTEC-specific deletion of Inhba (Activin A) reduces Activin B expression in a murine model of renal fibrosis. This thesis tested the hypothesis that Activin A regulates Activin B expression through the transcription factor SOX9, and investigated whether this axis mediates paracrine crosstalk between PTECs and fibroblasts. Using HK-2 cells and a PTEC-specific Inhba knockout mouse model of unilateral ureteral obstruction (UUO), Activin A activation (via recombinant drug), and Activin A inhibition (via siRNA knockdown and neutralizing antibody), consistently and bidirectionally altered Activin B mRNA and protein expression, establishing that Activin A acts upstream of Activin B. Activin A was also shown to be both necessary, in vivo, and sufficient, in vitro, for nuclear SOX9 accumulation, a marker of its transcriptionally active state. Dual immunofluorescence further revealed that SOX9-positive PTECs were spatially associated with regions of enriched myofibroblast activation, and conditioned medium from Activin A-treated PTECs induced SOX9 expression in fibroblasts in an Activin B-dependent manner, though this latter effect did not reach statistical significance. Together, these findings support a model in which Activin A drives SOX9-dependent Activin B upregulation in PTECs, positioning this axis as a candidate mechanism of epithelial-fibroblast crosstalk and a potential therapeutic target in CKD."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33823","https://doi.org/10.71548/25593"],"dc:language.iso":["en"],"dc:rights":["Attribution-NonCommercial-NoDerivs 2.5 Canada"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/2.5/ca/"],"dc:title":["Activin A Promotes Activin B Upregulation Through SOX9 in Chronic Kidney Disease"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:32:20Z"}